Money /

Markets & Investing

The deal will see SF Holding acquire an 8.45 per cent stake in J&T for about HK$8.3 billion. Photo: Shutterstock Images
Banking & finance

SF Holding, J&T strike US$1 billion deal as Asian e-commerce booms

The agreement will help SF Holding expand its international businesses, according to the Shenzhen-based company.

Banking & finance

Growth in sovereign investors’ China exposure slows amid political tensions

13
Made in China 2025

Novartis, SciNeuro deal offers hope for 55 million suffering from Alzheimer’s

videocam
Made in China 2025

China’s weight-loss drug war: prices slashed up to 80% as obesity crisis worsens

Foreign, local firms fight for market share as number of overweight or obese adults could top 630 million by 2050, from 400 million in 2021.

There were more than 400 million overweight or obese adults in China in 2021, according to a study. Photo: Getty Images
There were more than 400 million overweight or obese adults in China in 2021, according to a study. Photo: Getty Images
Banking & finance

TCM firms eye Hong Kong IPOs to fuel global expansion

Over the past year, 34 innovation and technology, life and health science companies set up or expanded their operations in Hong Kong.

IPO

3 Chinese AI, robotics stocks gain in Hong Kong debuts

Zhipu AI, Iluvatar CoreX and Edge Medical raised US$1.2 billion in their share offerings.

Advertisement
Advertisement
Advertisement
Made in China 2025

Chinese biotechs strike a record US$136 billion in out-licensing deals in 2025

Chinese drug makers signed 157 out-licensing deals with global pharmaceutical firms last year versus 94 a year earlier.

Last year, China approved 76 innovative drugs, including 47 chemical drugs and 23 biologics. Photo: Shutterstock
Last year, China approved 76 innovative drugs, including 47 chemical drugs and 23 biologics. Photo: Shutterstock
Made in China 2025

Meow or never: China’s pudgy pets spark race for weight-loss drugs

Fosun and Huadong biotech labs eye feline obesity drugs as owners weigh cuteness against health risks.

Banking & finance

The ‘biology winter’ thaws: why investors are buying Hong Kong’s biotech IPOs

A wave of China out-licensing deals is feeding a biotech comeback in Hong Kong, where IPOs and follow-on placements are surging.

Hong Kong stock market

Hong Kong stocks jump into 2026 with biggest surge since May

Investors expect Beijing’s ‘policy pivot’ to continue, with a focus on demand-side stimulus and stabilising the housing market, analyst says.

A view of Exchange Square in Central, where Hong Kong’s bourse operator is based, on December 30, 2025. Photo: Sun Yeung
IPO

Insilico Medicine leads 6 Hong Kong IPOs, capping banner fundraising year

Debutants raise total of US$899 million as exchange wraps up one of the most active months for IPOs since 2021.

Executives of the six companies celebrate their listings in a gong ceremony at Hong Kong Exchanges and Clearing in Central on December 30, 2025. Photo: Sun Yeung
Executives of the six companies celebrate their listings in a gong ceremony at Hong Kong Exchanges and Clearing in Central on December 30, 2025. Photo: Sun Yeung
Hong Kong stock market

Firmer yuan fuels share gains on bets Beijing will tolerate appreciation

Chinese equities edged higher on Friday, led by BYD, after the offshore yuan climbed through 7 per dollar for the first time since 2024.

China stock market

China stocks recover from early losses on cautious PBOC policy tone

Mainland stocks closed higher after paring earlier losses as investors read the central bank’s latest messaging as supportive but restrained.

Hong Kong stock market

Hong Kong stocks reverse gains as investors take profits before Christmas break

Losses in tech heavyweights like Kuaishou, Tencent and Xiaomi pull Hang Seng Index lower after advancing in the morning session.

Tourists take photos under the Christmas decorations outside the Ocean Terminal in Tsim Sha Tsui. Photo: Jelly Tse
Banking & finance

Gold takes centre stage as Hong Kong builds commodities ecosystem

Hong Kong plans to build an international gold trading centre as part of a wider commodities hub push.

Gold bricks displayed at Hong Kong Gold Exchange Chinese New Year Opening Ceremony in Sheung Wan. Photo: Edmond So
Gold bricks displayed at Hong Kong Gold Exchange Chinese New Year Opening Ceremony in Sheung Wan. Photo: Edmond So
IPO

Charles Li halts Hong Kong IPO plan for Micro Connect fund under HKEX Chapter 21

Former HKEX chief shifts to private fund model after regime fails to see a successful listing in a decade, raising call for a review.

Banking & finance

Chinese AI, chip start-ups court global investors with Hong Kong listing plans

GigaDevice and Montage are each aiming to raise as much as US$1 billion from Hong Kong listings as early as January, report says.

Advertisement
Advertisement
Advertisement
Mergers & Acquisitions

Chinese brokerage CICC unveils merger details with Dongxing, Cinda

The three-way merger will create China’s fourth-largest investment bank with assets of US$128 billion.

CICC will issue some 3.1 billion new A shares at 36.91 yuan to acquire all outstanding shares in Dongxing Securities and Cinda Securities to facilitate the merger. Photo: CFOTO/Future Publishing via Getty Images
CICC will issue some 3.1 billion new A shares at 36.91 yuan to acquire all outstanding shares in Dongxing Securities and Cinda Securities to facilitate the merger. Photo: CFOTO/Future Publishing via Getty Images
Hong Kong stock market

Standard Chartered keeps overweight call on China stocks, flags recovery in 2026

Despite renewed ‘bubble’ talk around AI valuations after a November sell-off, Standard Chartered says the cycle is different this time.

MetaX

MetaX stock soars 700% in Shanghai debut as traders snap up Chinese GPU maker

MetaX closes at 829.90 yuan on Wednesday, from its IPO price of 104.66 yuan, after gaining as much as 755 per cent in intraday trading.

IPO

China’s generative AI tiger MiniMax pursues Hong Kong IPO to expand global reach

Hong Kong equity market offers platform for mainland Chinese AI firms seeking international investors amid intensifying domestic competition.

MiniMax plans to beef up its research and development. Photo: Handout
Hong Kong stock market

Hong Kong stocks advance as traders position for additional growth measures

Investors anticipate further easing on monetary, fiscal and property fronts after Beijing vowed to strengthen domestic market.

Traders are hoping authorities will roll out further pro-growth initiatives to better align supply with domestic consumption, according to analysts. Photo: AFP
Traders are hoping authorities will roll out further pro-growth initiatives to better align supply with domestic consumption, according to analysts. Photo: AFP
Hong Kong stock market

Hong Kong stocks end flat as traders await policy signals from China conference

Investors look to CEWC for growth target, property sector stabilisation and measures to boost domestic demand.

IPO

Hong Kong’s IPO juggernaut projected to raise up to US$45 billion in 2026: KPMG

It will be a pivotal year for hi-tech listings, which will help cement Hong Kong’s place at the top of global markets, auditing firm says.

Made in China 2025

China’s Fosun Pharma unit strikes US$2.1 billion obesity drug deal with Pfizer

Yao Pharma’s deal with the US pharmaceutical giant underscores China’s growing role in global biotech licensing.

The collaboration is “another significant milestone in Fosun Pharma’s strategy of innovation and internationalisation”, according to the company. Photo: Reuters
Help preserve 120 years of quality journalism.
SUPPORT NOW